Gao et al. (84) found high USP29, HIF1α and GLUT1 levels in sorafenib-resistant PDX tumours, and follow-up research revealed that USP29-induced sorafenib resistance by mediating HIF1α stabilisation and upregulated glycolysis. Here, HIF1A is linked to neoplasm.